Menu
Stock Lookup
Search by symbol or company name, then inspect the chart and stock properties.
US
RARE Ultragenyx Pharmaceutical Inc.
TradingView
As Of 6/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
24.4000
Day %
2.09%
RS
15
RS 1D
13
RS 1W
11
RS 1M
29
RS 3M
5
RS 6M
38
Consensus Rating
Buy
Current Quarter EPS
-1.50
Next Quarter EPS
-1.31
Current Year EPS
-4.44
Next Year EPS
-0.37
ExchangeUS
Market Cap2 B
52W High39.8900
From 52W High-38.83%
Open24.0800
High24.7800
Low24.0050
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-06-12
Bars Available309
Scanner Hits0
Last Scanner HitNever
Recent Scanner History
0 matching / 0 totalThis stock has not shown up in any persisted scanner results yet.
Analyst Snapshot
As Of 3/29/26| Consensus | Current Quarter EPS | Next Quarter EPS | Current Year EPS | Next Year EPS |
|---|---|---|---|---|
| Buy | -1.50 | -1.31 | -4.44 | -0.37 |
Based on 19 analysts offering recommendations for 'RARE'.
Quarterly EPS Forecasts
5 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2026 | -1.50 | -1.06 | -2.01 | 9 |
▲
0
▼
1
|
| Jun 2026 | -1.31 | -1.20 | -1.44 | 7 |
▲
0
▼
1
|
| Sep 2026 | -0.90 | 0.23 | -1.36 | 7 |
▲
0
▼
0
|
| Dec 2026 | -0.53 | 0.60 | -0.86 | 7 |
▲
1
▼
0
|
| Mar 2027 | -0.17 | 0.28 | -0.61 | 2 |
▲
0
▼
0
|
Yearly EPS Forecasts
4 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -4.44 | -2.00 | -5.12 | 11 |
▲
0
▼
1
|
| Dec 2027 | -0.37 | 5.66 | -3.02 | 9 |
▲
1
▼
0
|
| Dec 2028 | 0.94 | 2.48 | -1.27 | 3 |
▲
0
▼
0
|
| Dec 2029 | 2.45 | 5.88 | -0.98 | 2 |
▲
0
▼
0
|